SEARCH

SEARCH BY CITATION

References

  • 1
    Garland SM. Human papillomavirus update with a particular focus on cervical disease. Pathology 2002;34:21324.
  • 2
    Armstrong DKB, Maw RD, Dinsmore WW, Blaakaer J, Correa MA, Falk L, et al. Combined therapy trial with interferon alpha-2a and ablative therapy in the treatment of anogenital warts. Genitourin Med 1996;72:1037.
  • 3
    Campoli-Richards DM, Sorkin EM, Heel RC. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1986;32:383424.
  • 4
    Mohanty KC, Scott CS. Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study. Genitourin Med 1986;62:3525.
  • 5
    Davidson-Parker J, Dinsmore W, Khan MH, Hicks DA, Morris CA, Morris DF. Immunotherapy of genital warts with inosine pranobex and conventional treatment: double blind placebo controlled study. Genitourin Med 1988;64:3836.
  • 6
    Sadoul G, Beuret T. Treatment of cervical and vulvar condylomata by CO2 laser with an immunostimulant. Rev Fr Gynecol Obstet 1984;79:6814.
  • 7
    O’Neill BB, Robins DS. Isoprinosine in the treatment of genital warts. Cancer Detect Prev 1988;12:497501.
  • 8
    Wybran J, Faman JP, Gortz R. Inosiplex (isoprinosine): a review of its immunological and clinical effects in disease. Adv Pharmacol Ther 1982;6:12331.
  • 9
    Wybran J, Govaerts A, Appelboom T. Inosiplex a stimulating agent for normal human T cells and human leukocytes. J Immunol 1978;121:11847.
  • 10
    Hadden JW, Hadden EM, Coffey RG. Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation. Infect Immun 1976;13:3827.
  • 11
    Ballet JJ, Morin A, Schmitt C, Agrapart M. Effect of isoprinosine on in vitro proliferative responses of human lymphocytes stimulated by antigen. Int J Immunopharmacol 1982;4:1517.
  • 12
    Morin A, Ballet JJ. A recent review on in vitro and in vivo immunological activities of methisoprinol. Allergol Immunopathol (Madr) 1982;10:10914.